Carna Biosciences, Inc.
Develops kinase inhibitor drugs for oncology/autoimmune diseases & offers discovery support services.
4572 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 神戸市中央区港島南町一丁目５番５号
- Website:
- https://www.carnabio.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Carna Biosciences, Inc. is a clinical-stage biopharmaceutical company founded in 2003, specializing in the discovery and development of innovative kinase inhibitor drugs. The company focuses on creating small molecule therapies to address unmet medical needs in oncology, autoimmune diseases, and neurodegenerative disorders. Carna Biosciences operates a dual business model: advancing its proprietary drug pipeline for out-licensing and providing comprehensive drug discovery support services. These services include the manufacturing of kinase proteins, as well as offering profiling, screening, and assay development to support pharmaceutical and biotechnology research globally. The company leverages its deep expertise in kinase biology to develop novel therapeutic candidates.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-12 08:46 |
Registration Form
訂正有価証券届出書（組込方式）
|
Japanese | 325.6 KB | ||
| 2025-08-07 02:46 |
Registration Form
訂正有価証券届出書（組込方式）
|
Japanese | 243.9 KB | ||
| 2025-08-07 02:45 |
Registration Form
訂正有価証券届出書（組込方式）
|
Japanese | 244.0 KB | ||
| 2025-08-07 02:43 |
Interim Report
確認書
|
Japanese | 8.8 KB | ||
| 2025-08-07 02:42 |
Interim Report
半期報告書－第23期(2025/01/01－2025/12/31)
|
Japanese | 358.3 KB | ||
| 2025-07-11 08:47 |
Registration Form
有価証券届出書（組込方式）
|
Japanese | 393.6 KB | ||
| 2025-07-11 08:46 |
Registration Form
有価証券届出書（組込方式）
|
Japanese | 393.6 KB | ||
| 2025-07-11 08:45 |
Registration Form
有価証券届出書（組込方式）
|
Japanese | 392.8 KB | ||
| 2025-03-28 02:41 |
Regulatory News Service
臨時報告書
|
Japanese | 28.5 KB | ||
| 2025-03-26 02:11 |
Governance Information
内部統制報告書－第22期(2024/01/01－2024/12/31)
|
Japanese | 24.5 KB | ||
| 2025-03-26 02:10 |
Registration Form
確認書
|
Japanese | 8.7 KB | ||
| 2025-03-26 02:08 |
Annual Report
有価証券報告書－第22期(2024/01/01－2024/12/31)
|
Japanese | 1.3 MB | ||
| 2024-09-25 08:39 |
Regulatory News Service
臨時報告書
|
Japanese | 122.5 KB | ||
| 2024-08-08 02:51 |
Regulatory News Service
確認書
|
Japanese | 8.7 KB | ||
| 2024-08-08 02:50 |
Interim Report
半期報告書－第22期(2024/01/01－2024/12/31)
|
Japanese | 213.7 KB |
Automate Your Workflow. Get a real-time feed of all Carna Biosciences, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Carna Biosciences, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
